Researchers sought to address the needs of caregivers of patients with hematologic malignancies undergoing HSCT.
Researchers sought to determine whether ruxolitinib would improve clinical outcomes in patients with treatment-resistant PV.
Randomized trial compared effects of ginger oil, peppermint oil, and canola oil on CINV in patients receiving chemotherapy prior to bone marrow transplantation.
Researchers sought to determine whether a novel machine learning algorithm could help determine whether a patient has inherited or immune/acquired BMF.
Changes to primary endpoints of phase 3 cancer trials may be common and underreported, a study suggests.
Researchers sought to develop a clonal hematopoiesis risk score for patients with CHIP and CCUS to determine whether it can predict risk of developing myeloid neoplasm.
The probability that a cancer drug would receive FDA approval within 10 years of entering trials was 10.4%, researchers found.
The prospective, multicenter NEOetic study explored relationships between patient prognostic awareness and decisions regarding treatment.
In a study of 16,870 oncologists practicing in the United States, 21% left patient-facing roles between 2015 and 2022.
Pediatric cancer patients who develop MIS-C after COVID-19 have a worse clinical course than patients without MIS-C, a study suggests.
Cancer patients reported concerns about the risks that COVID-19 poses to themselves and their family, how delayed care might affect their outcomes, and the social and economic impacts of the pandemic.
A majority of editorial board members from high-impact hematology/oncology journals are non-Hispanic White men, according to a recent study.
Interview study explored how patients perceive the concept quality of cancer care in the outpatient setting.
Cancer patients who use telemedicine report better experiences than cancer patients treated in person, according to a new study.
A new pain assessment documentation tool is helping nurses in an ambulatory clinic better manage telephone triage in oncology care.
Researchers sought to develop an educational program to improve communication between patients and caregivers and doctors about care and clinical trials.
Study results show a new productivity scale measures the workloads of oncology nurse navigators and assists in increasing their productivity.
NMDP/Be The Match and the ASTCT seek to address inequities in HCT and cellular therapy.
The time-based deferrals for men who have sex with men (MSM) and women who have sex with MSM have been eliminated.
Researchers sought to determine a method of testing hematopoietic stem cell transplantation recipients for Clostridioides difficile as a cause of diarrhea.
During end-of-life care, cancer patients who utilized spiritual, psychology, and social work services received different oncologic treatment.
Researchers sought to determine the frequency of myeloid-derived suppressor cells in bone marrow of patients with MPN.
Researchers looked at the use of 6 biosimilars across 38 oncology practices and found that biosimilar use increased from 2019 to 2021.
The risk of in-hospital death from COVID-19 for patients with cancer differs by sex and cancer type, according to a new study.
A new study has revealed “stark” differences in cancer death rates between Asian patients and NHPI patients in the US, according to researchers.
A quality improvement project sought to reduce falls and falls with injury among inpatient hematology/oncology patients.
Researchers sought to determine whether using cryopreserved hematopoietic stem cell grafts during the COVID-19 pandemic impacted OS compared with fresh grafts.
A project designed to improve the interaction within a multidisciplinary team on a HSCT unit was presented at the 48th Annual ONS Congress.
A team of HSCT nurses developed a training program for oncology nurses to improve the care of patients with hematologic cancer outside the transplantation unit.
New research suggests that some cancer patients do not have their menstrual history documented and do not receive treatment for menstrual disturbances.
Omisirge is a nicotinamide modified allogeneic hematopoietic progenitor cell therapy derived from cord blood used as an allogeneic stem cell donor source.
Combination dabrafenib and trametinib has demonstrated activity against multiple rare cancers harboring the BRAF V600E mutation.
From 15 to 40 years after diagnosis, pediatric cancer survivors have a roughly 4-fold higher risk of death than the general population, a study suggests.
Compared to the general public, cancer survivors are more likely to use cannabis for medical purposes but less likely to use cannabis in general, a study suggests.
Researchers assessed clinical incidence of pruritus in patients with myeloproliferative neoplasms.
Researchers sought to determine whether responses to the pneumococcal vaccine would vary between patients after HCT at 3 or 6 months.
Researchers sought to identify the factors that resulted in a high proportion of African American patients with multiple myeloma participating in the Winship clinical trials.
Friends and family, especially parents, are the greatest sources of social support for childhood and adolescent cancer survivors.
Research has revealed regional disparities in outcomes for patients who are hospitalized with chemotherapy-related febrile neutropenia in the United States.
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.
A recent review highlights the burden of cisplatin-induced ototoxicity and the current state of monitoring and managing this condition.
NGS can reveal targetable mutations and aid diagnosis for patients with cancer of unknown primary, a study suggests.
Medical oncologists in the United States have been writing fewer prescriptions for opioids since 2017, a new study suggests.
Researchers sought to determine the impact of TP53 mutations on HSCT outcomes in patients with myelofibrosis.
Patients with cancer continued to experience COVID-19-related disruptions to their care in 2022, results of a survey suggest.
A retrospective cohort study sought to determine the impact distance from the clinic has on the likelihood of male patients with cancer to participate in fertility preservation.
Researchers sought to determine whether combination therapy with pelabresib and ruxolitinib would lead to improvements in spleen reduction volume in myelofibrosis.
The letter states that the application cannot be approved in its present form.
Researchers sought to determine the role of mutant calreticulin in the proliferation of hematopoietic cells in patients with MPNs.
Joenja is supplied as 70mg tablets in 60-count bottles; it is expected to be available in early April 2023.
Researchers sought to determine whether treatment with hydroxyurea for patients with MPNs would lead to a higher risk of secondary malignancies.